| Issue Date | Title | Author(s) |
| Nov-2022 | Blockage of PPAR gamma T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions | Yang, Nanfei; Wang, Yuxin; Tian, Qiang; Wang, Qiuping; Lu, Yan; Sun, Luchen; Wang, Sijie; Bei, Yuncheng; Ji, Jianguo; Zhou, Hu; Yang, Wei; Yao, Pengju; Zhu, Wenyuan; Sun, Lingyun; Huang, Zhifeng; Li, Xiaokun; Shen, Pingping |
| 26-Jul-2022 | Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study | Chong, Shan; Zhao, Peng; Huang, Rui-Bin; Zhou, Hu; Zhang, Jia-Ning; Hou, Ming; Liu, Yi; Yao, Hong-Xia; Niu, Ting; Peng, Jun; Jiang, Ming; Han, Yan-Qiu; Hu, Jian-Da; Zhou, Ze-Ping; Qiu, Lin; Zhang, Lian-Sheng; Wang, Xin; Wang, Hua-Quan; Feng, Ru; Yang, Lin-Hua; Ma, Liang-Ming; Wang, Shun-Qing; Kong, Pei-Yan; Wang, Wen-Sheng; Sun, Hui-Ping; Sun, Jing; Zhou, He-Bing; Zhu, Tie-Nan; Wang, Li-Ru; Zhang, Jing-Yu; Huang, Qiu-Sha; Fu, Hai-Xia; Wu, Ye-Jun; Li, Yue-Ying; Wang, Qian-Fei; Jiang, Qian; Jiang, Hao; Lu, Jin; Huang, Xiao-Jun; Zhang, Xiao-Hui |
| 2-Nov-2023 | Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF) | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Suo, Shanshan; Yu, Wenjuan; Jin, Jie |
| 2024 | Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yin, Hewen; Suo, Shanshan; Yu, Wenjuan; Jin, Jie |
| 2024 | Enzymatic Degradation of Deoxynivalenol with the Engineered Detoxification Enzyme Fhb7 | Yang, Jun; Liang, Kai; Ke, Han; Zhang, Yuebin; Meng, Qian; Gao, Lei; Fan, Junping; Li, Guohui; Zhou, Hu; Xiao, Junyu; Lei, Xiaoguang |
| Sep-2020 | Facile in situ synthesis of silver nanocomposites based on cellulosic paper for photocatalytic applications | Yuan, Zhengqiu; Yang, Huizhi; Xu, Pan; Li, Chengfeng; Jian, Jian; Zeng, Jianxian; Zeng, Lingwei; Sui, Yuguang; Zhou, Hu |
| 2016 | Graphene Oxide Catalyzed C-H Bond Activation: The Importance of Oxygen Functional Groups for Biaryl Construction | Gao, Yongjun; Tang, Pei; Zhou, Hu; Zhang, Wei; Yang, Hanjun; Yan, Ning; Hu, Gang; Mei, Donghai; Wang, Jianguo; Ma, Ding |
| 2015 | Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5 | Huang, Yue; Yan, Jingli; Li, Qi; Li, Jiafei; Gong, Shouzhe; Zhou, Hu; Gan, Jianhua; Jiang, Hualiang; Jia, Gui-Fang; Luo, Cheng; Yang, Cai-Guang |
| 25-Feb-2021 | A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia | Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Zhang, Liansheng; Zheng, Changcheng; Shen, Xuliang; Hu, Qi; Liu, Jing; Jin, Jie; Luo, Jianmin; Zeng, Yun; Gao, Sujun; Zhang, Xiaohui; Zhou, Xin; Shi, Qingzhi; Xia, Ruixiang; Xie, Xiaobao; Jiang, Zhongxing; Gao, Li; Bai, Yuansong; Li, Yan; Xiong, Junye; Li, Runzi; Zou, Jianjun; Niu, Ting; Yang, Renchi; Hu, Yu |
| 1-Jun-2023 | A randomized, double-blind, phase 3 study of jaktinib versus hydroxyurea (HU) in patients (pts) with intermediate-2 or high-risk myelofibrosis (MF). | Zhang, Yi; Zhou, Hu; Zhuang, Junling; He, Aili; Li, Yarong; Yang, Linhua; Du, Xin; Gao, Sujun; He, Guangsheng; Hong, Mei; Jiang, Qian; Jiang, Zhongxing; Sun, Kai; Yue, Lingling; Zheng, Cuiping; Zhou, Zeping; Xiao, Zhi-Jian; Jin, Jie |
| Jul-2020 | Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age | Zhao, Peng; Hou, Ming; Liu, Yi; Liu, Hui-Xin; Huang, Rui-Bin; Yao, Hong-Xia; Niu, Ting; Peng, Jun; Jiang, Ming; Han, Yan-Qiu; Hu, Jian-Da; Zhou, Hu; Zhou, Ze-Ping; Qiu, Lin; Zhang, Lian-Sheng; Wang, Xin; Wang, Hua-Quan; Feng, Ru; Yang, Lin-Hua; Ma, Liang-Ming; Wang, Shun-Qing; Kong, Pei-Yan; Wang, Wen-Sheng; Sun, Hui-Ping; Sun, Jing; Zhou, He-Bing; Zhu, Tie-Nan; Wang, Li-Ru; Zhang, Jing-Yu; Huang, Qiu-Sha; LiU, Xiao; Fu, Hai-Xia; Li, Yue-Ying; Wang, Qian-Fei; Jiang, Qian; Jiang, Hao; Lu, Jin; Zhang, Xiao-Hui |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
| Oct-2022 | Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yu, Wenjuan; Jin, Jie |
